TWI331142B - - Google Patents
Download PDFInfo
- Publication number
- TWI331142B TWI331142B TW093121149A TW93121149A TWI331142B TW I331142 B TWI331142 B TW I331142B TW 093121149 A TW093121149 A TW 093121149A TW 93121149 A TW93121149 A TW 93121149A TW I331142 B TWI331142 B TW I331142B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- substituted
- ring
- alkyl
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003274684 | 2003-07-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200523249A TW200523249A (en) | 2005-07-16 |
| TWI331142B true TWI331142B (https=) | 2010-10-01 |
Family
ID=34113749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093121149A TW200523249A (en) | 2003-07-15 | 2004-07-15 | Novel heteroaryl derivative |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7425642B2 (https=) |
| EP (1) | EP1647546B1 (https=) |
| JP (2) | JP4820169B2 (https=) |
| KR (1) | KR101086654B1 (https=) |
| CN (1) | CN100516041C (https=) |
| AT (1) | ATE556051T1 (https=) |
| CA (1) | CA2531064C (https=) |
| ES (1) | ES2383895T3 (https=) |
| MX (1) | MXPA06000539A (https=) |
| TW (1) | TW200523249A (https=) |
| WO (1) | WO2005012245A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2006075638A1 (ja) * | 2005-01-14 | 2008-06-12 | 大日本住友製薬株式会社 | 新規ヘテロアリール誘導体 |
| US20060241073A1 (en) * | 2005-04-20 | 2006-10-26 | Wanders Ronaldus J A | Means and methods for counteracting fatty acid accumulation |
| AU2007292155B2 (en) | 2006-09-05 | 2012-11-01 | Kyowa Kirin Co., Ltd. | Imidazole derivative |
| WO2008157537A2 (en) * | 2007-06-19 | 2008-12-24 | Ironwood Pharmaceuticals, Inc | Compositions and methods of use for treating or preventing lipid related disorders |
| JPWO2010050422A1 (ja) * | 2008-10-31 | 2012-03-29 | 大日本住友製薬株式会社 | 糖尿病治療剤 |
| US20120010264A1 (en) * | 2009-03-26 | 2012-01-12 | Dainippon Sumitomo Pharma Co., Ltd. | Novel medicament for treating cognitive impairment |
| JPWO2011002012A1 (ja) * | 2009-07-01 | 2012-12-13 | キッセイ薬品工業株式会社 | Ｓｇｌｔ１阻害薬とインスリン抵抗性改善薬を組み合わせてなる医薬 |
| MX336731B (es) | 2010-01-28 | 2016-01-28 | Harvard College | Composiciones y metodos para potenciar la actividad de proteasoma. |
| WO2012007500A2 (de) | 2010-07-15 | 2012-01-19 | Bayer Cropscience Ag | Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| DK2707101T3 (da) | 2011-05-12 | 2019-05-13 | Proteostasis Therapeutics Inc | Proteostaseregulatorer |
| US10266490B2 (en) * | 2012-03-16 | 2019-04-23 | Georgetown University | Radioprotector compounds |
| US9849135B2 (en) | 2013-01-25 | 2017-12-26 | President And Fellows Of Harvard College | USP14 inhibitors for treating or preventing viral infections |
| WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2752361A1 (de) * | 1977-11-24 | 1979-06-07 | Troponwerke Gmbh & Co Kg | Neue indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US6177443B1 (en) * | 1997-03-07 | 2001-01-23 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use |
| JP2001514631A (ja) | 1997-03-07 | 2001-09-11 | ノボ ノルディスク アクティーゼルスカブ | ４，５，６，７−テトラヒドロ−チエノ［３，２−ｃ］ピリジン誘導体類、それらの製造方法及び使用 |
| US6911468B2 (en) * | 2000-05-22 | 2005-06-28 | Takeda Chemical Industries, Ltd. | Tyrosine phosphatase inhibitors |
| JP2002121186A (ja) | 2000-05-22 | 2002-04-23 | Takeda Chem Ind Ltd | チロシンホスファターゼ阻害剤 |
| IL152771A0 (en) * | 2000-06-26 | 2003-06-24 | Pfizer Prod Inc | PYRROLO(2,3-d) PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| DE60227655D1 (de) * | 2001-04-19 | 2008-08-28 | Dainippon Sumitomo Pharma Co | Pyrrolderivat |
| JP2003171275A (ja) | 2001-12-11 | 2003-06-17 | Sumitomo Pharmaceut Co Ltd | ＰＰＡＲδアゴニスト |
| AU2003284479A1 (en) | 2002-11-28 | 2004-06-18 | Sumitomo Pharmaceuticals Co., Ltd. | Novel heteroaryl derivative |
-
2004
- 2004-07-13 AT AT04747746T patent/ATE556051T1/de active
- 2004-07-13 EP EP04747746A patent/EP1647546B1/en not_active Expired - Lifetime
- 2004-07-13 JP JP2005512472A patent/JP4820169B2/ja not_active Expired - Fee Related
- 2004-07-13 ES ES04747746T patent/ES2383895T3/es not_active Expired - Lifetime
- 2004-07-13 CA CA2531064A patent/CA2531064C/en not_active Expired - Fee Related
- 2004-07-13 MX MXPA06000539A patent/MXPA06000539A/es active IP Right Grant
- 2004-07-13 US US10/563,361 patent/US7425642B2/en not_active Expired - Fee Related
- 2004-07-13 KR KR1020067000907A patent/KR101086654B1/ko not_active Expired - Fee Related
- 2004-07-13 CN CNB2004800262352A patent/CN100516041C/zh not_active Expired - Fee Related
- 2004-07-13 WO PCT/JP2004/010282 patent/WO2005012245A1/ja not_active Ceased
- 2004-07-15 TW TW093121149A patent/TW200523249A/zh not_active IP Right Cessation
-
2008
- 2008-07-15 US US12/173,792 patent/US20080306275A1/en not_active Abandoned
-
2011
- 2011-07-07 JP JP2011151138A patent/JP2011251974A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005012245A1 (ja) | 2005-02-10 |
| CA2531064C (en) | 2012-05-22 |
| US20080306275A1 (en) | 2008-12-11 |
| US20060194857A1 (en) | 2006-08-31 |
| CA2531064A1 (en) | 2005-02-10 |
| ATE556051T1 (de) | 2012-05-15 |
| US7425642B2 (en) | 2008-09-16 |
| ES2383895T3 (es) | 2012-06-27 |
| EP1647546A4 (en) | 2008-07-23 |
| HK1087409A1 (en) | 2006-10-13 |
| CN1849303A (zh) | 2006-10-18 |
| JPWO2005012245A1 (ja) | 2006-09-14 |
| KR20060040681A (ko) | 2006-05-10 |
| JP2011251974A (ja) | 2011-12-15 |
| CN100516041C (zh) | 2009-07-22 |
| MXPA06000539A (es) | 2006-03-30 |
| TW200523249A (en) | 2005-07-16 |
| EP1647546A1 (en) | 2006-04-19 |
| JP4820169B2 (ja) | 2011-11-24 |
| EP1647546B1 (en) | 2012-05-02 |
| KR101086654B1 (ko) | 2011-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352492B (zh) | 以芳基磺酰基衍生物作为有效成分的长链脂肪酸延长酶抑制剂 | |
| TWI313264B (en) | Triamide-substituted heterobicyclic compounds | |
| CN109996797B (zh) | 作为乳酸脱氢酶的抑制剂的1h-吡唑-1-基-噻唑及其使用方法 | |
| JP2011251974A (ja) | 新規ヘテロアリール誘導体 | |
| TW201420565A (zh) | 吡咯磺醯類衍生物、其製備方法及其在醫藥上的應用 | |
| EA009518B1 (ru) | Соединения, модулирующие активность ppar, и способы их получения | |
| CN101939053A (zh) | 可溶性的鸟苷酸环化酶活化剂 | |
| TW200914449A (en) | Organic compounds | |
| CN105339350B (zh) | 二氢吡啶酮mgat2抑制剂 | |
| WO2017180457A1 (en) | Gpr40 agonists in anti-diabetic drug combinations | |
| JP3826400B2 (ja) | ラクタム化合物及びその医薬用途 | |
| CN106748922A (zh) | 一类新型砜酸衍生物、其制备方法及其作为药物的用途 | |
| CN107162921B (zh) | 一类苯氧乙酸衍生物、其制备方法及其作为药物的用途 | |
| CN1980894A (zh) | 作为ppar调节剂的化合物和组合物 | |
| WO2003091211A1 (en) | Novel heteroaryl compounds | |
| CN108069954B (zh) | 含no供体的喹唑啉酮化合物 | |
| JP2009506127A (ja) | 糖尿病の処置に有用なアニリノピラゾール誘導体 | |
| CN109748914A (zh) | 吡啶并嘧啶类化合物及其应用 | |
| TW201028152A (en) | Soluble guanylate cyclase activators | |
| KR101524208B1 (ko) | 벤조옥사졸 유도체, 이의 제조방법 및 이를 포함하는 의약 조성물 | |
| TW201141476A (en) | Novel indole derivative | |
| TW202206409A (zh) | 用於ｕｂｒ盒結構域配體之化合物以及醫藥組成物 | |
| CN107162913A (zh) | 一类新型氘代苯丙酸衍生物、其制备方法及其作为药物的用途 | |
| WO2004048341A1 (ja) | 新規ヘテロアリール誘導体 | |
| CN108785292B (zh) | 氨基-芳基-苯甲酰胺化合物及其使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |